These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 764846)

  • 21. Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia.
    Ritch PS; McCredie KB; Gutterman JU; Hersh EM
    Cancer; 1978 Jul; 42(1):167-70. PubMed ID: 276413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte function in myeloblastic leukaemia.
    Wilkinson PM; Sumner C; Delamore IW; Geary CG; Milner GR
    Br J Cancer; 1975 Nov; 32(5):574-7. PubMed ID: 764849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.
    Joseph RR; Belpomme D; Mathé G
    Br J Cancer; 1976 May; 33(5):567-70. PubMed ID: 776199
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acute myeloide leukaemia (A.M.L.): comparative toxicity of chemotherapy and chemo-immunotherapy].
    Vu Van H; Doillon M; Fière D; Bryon PA; Vesseyre C
    Nouv Presse Med; 1978 Dec; 7(43):3931. PubMed ID: 282588
    [No Abstract]   [Full Text] [Related]  

  • 25. Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
    Harris R; Zuhrie SR; Freeman CB; Taylor GM; MacIver JE; Geary CG; Delamore IW; Hull PJ; Tooth JA
    Br J Cancer; 1978 Feb; 37(2):282-8. PubMed ID: 272913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy of chronic myelocytic leukemia.
    Sokal JE; Aungst CW; Grace JT
    Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunotherapy in the management of myelogenous leukemia.
    Fairley GH
    Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myelocytic leukemia.
    Holland JF; Glidewell O; Ellison RR; Corey RW; Schwartz J; Wallace HJ; Hoagland HC; Wiernik P; Rai K; Bekesi JG; Cuttner J
    Arch Intern Med; 1976 Dec; 136(12):1377-81. PubMed ID: 793552
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of leukemia specific antigen and immunotherapy of acute leukemia with cell-wall skeleton of BCG.
    Ohno R; Ezaki K; Morishima Y; Kodera Y; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1134-41. PubMed ID: 87101
    [No Abstract]   [Full Text] [Related]  

  • 30. [Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].
    Mathe G; Amiel JL; Schwarsenberg L; Hyat M; Pouillart P; Schenider M; Cattan A; Jasmin C; Belpomme D; Schulmberger JR; De Vassal F; Musset M; Misset JL
    Folia Clin Int (Barc); 1975 Mar; 25(3):131-51. PubMed ID: 1056311
    [No Abstract]   [Full Text] [Related]  

  • 31. [BCG, or immunotherapy of hope].
    Monti A
    Minerva Med; 1975 Oct; 66(68 Suppl):7-9. PubMed ID: 1059000
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant immunotherapy with BCG of acute myeloid leukemia: a 15-year follow-up.
    Reizenstein P
    Br J Haematol; 1990 Jun; 75(2):288-9. PubMed ID: 2196933
    [No Abstract]   [Full Text] [Related]  

  • 33. Mixed b.c.g. and irradiated-cell immunotherapy in acute leukemia.
    Zuhrie SR; Harris R; Geary C
    Lancet; 1978 Jan; 1(8054):53. PubMed ID: 74538
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunotherapy of acute myeloid leukaemia. Medical Research Council.
    Br J Cancer; 1978 Jan; 37(1):1-14. PubMed ID: 339940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemo-immunotherapy versus chemotherapy in acute myeloid leukemia. Preliminary results.
    Fiere D; Doillon M; Martin C; Vu Van T; Revol L
    Biomedicine; 1976 Dec; 25(9):318. PubMed ID: 1069595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Our experience in using chemo- and immunotherapy for children with acute leukemia].
    Blau HI; Schultz M
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):25-6. PubMed ID: 6946412
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of immunotherapy in the treatment of leukemias].
    Alexander P
    Recenti Prog Med; 1975 Oct; 59(4):301-13. PubMed ID: 769101
    [No Abstract]   [Full Text] [Related]  

  • 38. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 39. [Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases].
    Mathé G; Amiel JL; Schwarzenberg L; Hayat M; Pouillart P; Schneider M; Cattan A; Jasmin C; Belpomme D; Schlumberger JR; De Vassal F; Musset M; Misset JL
    Nouv Presse Med; 1975 May; 4(18):1337-42. PubMed ID: 1098015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
    Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F
    Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.